Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Proteomic analysis of hypertrophied myocardial protein patterns in renovascularly hypertensive and spontaneously hypertensive rats.

Literature DB >> 17081041

Proteomic analysis of hypertrophied myocardial protein patterns in renovascularly hypertensive and spontaneously hypertensive rats.

Si-Gui Zhou¹, Shu-Feng Zhou, He-Qing Huang, Jian-Wen Chen, Min Huang, Pei-Qing Liu.

Abstract

The cardiac protein profiles of spontaneously hypertensive and renovascularly hypertensive hypertrophy showed a significant alteration compared with normal hearts. Most proteins with significant modulations in their expressions belong to the category of metabolic and stress-related proteins. Among these proteins, glutathione-S-transferase mu2 and short-chain acyl-CoA dehydrogenase may be two candidate proteins associated with left ventricular hypertrophy in spontaneously hypertensive rats.

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2006 PMID： 17081041 DOI： 10.1021/pr050456l

Source DB: PubMed Journal: J Proteome Res ISSN： 1535-3893 Impact factor: 4.466

Keyword Cloud
Cited

16 in total

1. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.

Authors: Xiuli Fang; Yajun Liu; Jing Lu; Huiqi Hong; Jing Yuan; Yuhong Zhang; Panxia Wang; Peiqing Liu; Jiantao Ye
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2018-08-21 Impact factor: 3.000

2. The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1.

Authors: Xiao-Jun Feng; Hui Gao; Si Gao; Zhuoming Li; Hong Li; Jing Lu; Jiao-Jiao Wang; Xiao-Yang Huang; Min Liu; Jian Zou; Jian-Tao Ye; Pei-Qing Liu
Journal: Br J Pharmacol Date: 2015-03-26 Impact factor: 8.739

3. Sirtuin 1 represses PKC-ζ activity through regulating interplay of acetylation and phosphorylation in cardiac hypertrophy.

Authors: Jingyan Li; Junying Huang; Jing Lu; Zhen Guo; Zhuoming Li; Hui Gao; Panxia Wang; Wenwei Luo; Sidong Cai; Yuehuai Hu; Kaiteng Guo; Luping Wang; Zhenzhen Li; Minghui Wang; Xiaolei Zhang; Peiqing Liu
Journal: Br J Pharmacol Date: 2018-12-09 Impact factor: 8.739

4. G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway.

Authors: Hui-Qi Hong; Jing Lu; Xiu-Li Fang; Yu-Hong Zhang; Yi Cai; Jing Yuan; Pei-Qing Liu; Jian-Tao Ye
Journal: Acta Pharmacol Sin Date: 2017-08-17 Impact factor: 6.150

5. Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity.

Authors: Shan-Shan Yu; Yi Cai; Jian-Tao Ye; Rong-Biao Pi; Shao-Rui Chen; Pei-Qing Liu; Xiao-Yan Shen; Yong Ji
Journal: Br J Pharmacol Date: 2013-01 Impact factor: 8.739

6. Synthesis of the novel PARP-1 inhibitor AG-690/11026014 and its protective effects on angiotensin II-induced mouse cardiac remodeling.

Authors: Guo-Shuai Feng; Cui-Ge Zhu; Zhuo-Ming Li; Pan-Xia Wang; Yi Huang; Min Liu; Ping He; Lan-Lan Lou; Shao-Rui Chen; Pei-Qing Liu
Journal: Acta Pharmacol Sin Date: 2017-02-27 Impact factor: 6.150

7. Metabolic alterations derived from absence of Two-Pore Channel 1 at cardiac level.

Authors: Vanessa Garcia-Rua; Sandra Feijoo-Bandin; Maria Garcia-Vence; Alana Aragon-Herrera; Susana B Bravo; Diego Rodriguez-Penas; Ana Mosquera-Leal; Pamela V Lear; John Parrington; Jana Alonso; Esther Rosello-Lleti; Manuel Portoles; Miguel Rivera; Jose Ramon Gonzalez-Juanatey; Francisca Lago
Journal: J Biosci Date: 2016-12 Impact factor: 1.826